Skip to main content
. 2016 Nov 8;7(51):85079–85096. doi: 10.18632/oncotarget.13196

Table 2. Univariate and multivariate analysis of overall survival (OS) in hepatocellular carcinoma.

Variables n Univariate Analysis Multivariate Analysis
HR (95% CI) P HR (95% CI) P
Age (years)
 <50 44 0.791(0.455-1.374) 0.405
 ≥50 57
Gender
 Female 46 0.726(0.418-1.259) 0.254
 Male 55
Tumor size(cm)
 <5 44 0.576(0.330-1.006) 0.053
 ≥5 57
Histologic grade
 Poor 39 2.558(1.267-5.164) 0.009 2.377(1.164-4.854) 0.017
 Moderate 32
 Well 30
Liver cirrhosis
 Absence 36 0.792(0.440-1.425) 0.437
 Presence 65
Serum AFP (ng/ml)
 ≤400 35 0.914(0.524-1.594) 0.752
 >400 66
BCLC stage
 A 18 0.372(0.150-0.923) 0.033 0.480(0.169-1.364) 0.168
 B 36
 C 47
HBV
 Negative 11 0.377(0.117-1.212) 0.102
 Positive 90
Microvascular invasion
 NO 54 0.546(0.316-0.942) 0.030 0.617(0.338-1.124) 0.115
 Yes 47
IL-37 expression
 High 51 0.496(0.285-0.863) 0.013 0.555(0.308-0.999) 0.050
 Low 50

AFP, α-fetoprotein;BCLC stage, Barcelona Clinic Liver Cancer stage;HBV, hepatitis B virus;